DrugPatentWatch Database Preview
Duchesnay Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for DUCHESNAY, and what generic alternatives to DUCHESNAY drugs are available?
DUCHESNAY has three approved drugs.
There are fourteen US patents protecting DUCHESNAY drugs.
There are one hundred and ninety-two patent family members on DUCHESNAY drugs in fifty-three countries and fourteen supplementary protection certificates in twelve countries.
Summary for Duchesnay
| International Patents: | 192 |
| US Patents: | 14 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 3 |
| Patent Litigation for Duchesnay: | See patent lawsuits for Duchesnay |
Drugs and US Patents for Duchesnay
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | RX | Yes | Yes | 8,772,353 | Start Trial | Start Trial | ||||
| Duchesnay | DICLEGIS | doxylamine succinate; pyridoxine hydrochloride | TABLET, DELAYED RELEASE;ORAL | 021876-001 | Apr 8, 2013 | AB | RX | Yes | Yes | 6,340,695 | Start Trial | Y | Start Trial | ||
| Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | RX | Yes | Yes | 9,855,224 | Start Trial | Start Trial | ||||
| Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | RX | Yes | Yes | 7,560,122 | Start Trial | Y | Start Trial | |||
| Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | RX | Yes | Yes | 8,236,861 | Start Trial | Start Trial | ||||
| Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | RX | Yes | Yes | 9,089,489 | Start Trial | Y | Start Trial | |||
| Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | RX | Yes | Yes | 8,642,079 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Duchesnay
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Duchesnay | DICLEGIS | doxylamine succinate; pyridoxine hydrochloride | TABLET, DELAYED RELEASE;ORAL | 021876-001 | Apr 8, 2013 | 7,560,122 | Start Trial |
| Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | 7,560,122 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for DUCHESNAY drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 20 mg/20 mg | ➤ Subscribe | 2018-08-28 |
| ➤ Subscribe | Delayed-release Tablets | 10 mg/10 mg | ➤ Subscribe | 2013-08-01 |
International Patents for Duchesnay Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hungary | 0301950 | Start Trial |
| South Africa | 200300342 | Start Trial |
| Belgium | 1014929 | Start Trial |
| Taiwan | 200400835 | Start Trial |
| Mexico | 2014008594 | Start Trial |
| Denmark | 1305014 | Start Trial |
| Brazil | 112017004190 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Duchesnay Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1713458 | CA 2015 00031 | Denmark | Start Trial | PRODUCT NAME: OSPEMIFENE; REG. NO/DATE: EU/1/14/978/001-002 20150115 |
| 1713458 | 576 | Finland | Start Trial | |
| 1713458 | 122015000048 | Germany | Start Trial | PRODUCT NAME: OSPEMIFEN IN ALLEN DEM GRUNDPATENT ZUGRUNDE LIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/14/978/001-002 20150115 |
| 1713458 | 28/2015 | Austria | Start Trial | PRODUCT NAME: OSPEMIFEN; REGISTRATION NO/DATE: EU/1/14/978/001-002 20150119 |
| 1713458 | C20150029 00165 | Estonia | Start Trial | PRODUCT NAME: OSPEMIFEEN;REG NO/DATE: EU/1/14/978 19.01.2015 |
| 1713458 | 2015/031 | Ireland | Start Trial | PRODUCT NAME: OSPEMIFENE OR A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER THEREOF; REGISTRATION NO/DATE: EU/1/14/978/001-002 20150115 |
| 1713458 | 1590030-1 | Sweden | Start Trial | PRODUCT NAME: OSPEMIFENE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/14/978/001 20150119 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
